Revitalized Mixed-Use Campus Delivers 300,000 Square Feet of Life Science Lab, R&D and Class A Office in Seattle, WA
Campus Design Focuses on Wellness Amenities and Connection to Surrounding.
Sonoma Bio celebrates new Seattle waterfront R&D center for autoimmune disease research geekwire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from geekwire.com Daily Mail and Mail on Sunday newspapers.
Sonoma Biotherapeutics to receive $75 million upfront, inclusive of $45 million cash and $30 million equity investment; potential for an additional $45 million development milestone paymentTARRYTOWN,. | March 28, 2023
Sonoma Biotherapeutics to receive $75 million upfront, inclusive of $45 million cash and $30 million equity investment; potential for an additional $45 million development milestone payment
. | March 28, 2023
Regeneron Pharmaceuticals Inc. and Sonoma Biotherapeutics Inc. announced a collaboration to apply their scientific and clinical expertise and respective technology platforms to the discovery, development and commercialization of novel regulatory T cell (Treg) therapies for autoimmune diseases.